| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PODD
Insulet
|
Apr 24, 2026 | HOLD |
Strong Buy
+79.0% avg upside
32 analysts
|
$220.00
50.97% Upside
|
-23.1% |
|
TNDM
Tandem Diabetes Care
|
Apr 24, 2026 | BUY |
Strong Buy
+116.0% avg upside
29 analysts
|
$45.00
194.15% Upside
|
-17.0% |
|
COO
Cooper Co
|
Mar 04, 2026 | HOLD |
Buy
+102.3% avg upside
21 analysts
|
$85.00
29.06% Upside
|
-17.8% |
|
CH:ALC
Alcon
|
Mar 04, 2026 | BUY |
Buy
+34.3% avg upside
35 analysts
|
$77.00
45.58% Upside
|
· |
|
CH:SOON
Sonova Holding AG
|
Oct 06, 2025 | HOLD |
Sell
+14.3% avg upside
17 analysts
|
$215.00
11.37% Upside
|
· |
|
FR:EL
EssilorLuxottica SA
|
Sep 17, 2025 | BUY |
Strong Buy
+13.0% avg upside
17 analysts
|
$320.00
84.37% Upside
|
· |
|
DXCM
Dexcom
|
Feb 03, 2025 | BUY |
Strong Buy
+38.6% avg upside
32 analysts
|
$115.00
58.73% Upside
|
-17.7% |
|
WILLF
Demant
|
Feb 19, 2021 | HOLD |
Strong Buy
+10.1% avg upside
19 analysts
|
— | +1.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.